Welcome to the e-CCO Library!

OP016: Potential role of bile acid receptor FXR in microscopic colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Palmela C.*1, Torres J.1, Gomes de Sena P.2, Costa Santos M.P.1, Gouveia C.1, Oliveira M.H.2, Rodrigues C.M.P.3, Cravo M.1, Borralho P.4,5

Created: Wednesday, 20 February 2019, 10:36 AM
OP017: Multi-donor intense faecal microbiota transplantation is an effective treatment for resistant ulcerative colitis: a randomised placebo-controlled trial
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Paramsothy*1, M. Kamm2, 3, A. Walsh4, J. van den Bogaerde5, D. Samuel6, R. Leong6, S. Connor7, W. Ng7, R. Paramsothy7, N. Kaakoush8, H. Mitchell8, W. Xuan9, E. Lin10, T. Borody10

Created: Friday, 22 February 2019, 9:49 AM
OP017: Telemedicine enables a safe shift from examination room based care to personalised care for inflammatory bowel disease: a pragmatic randomised multicenter trial with myIBDcoach
Year: 2017
Source: ECCO '17 Barcelona
Authors:

de Jong M.*1,2, van der Meulen-de Jong A.3, Romberg-Camps M.4, Becx M.5, Cilissen M.1, Maljaars J.3, van Bodegraven A.4, Mahmmod N.5, Markus T.6, Hameeteman W.1, Dijkstra G.7, Masclee A.1,2, Boonen A.8,9, Jonkers D.1,2, van Tubergen A.8,9, Pierik M.1,2

Created: Wednesday, 20 February 2019, 10:36 AM
OP017: Transanal minimally invasive proctectomy with ileal pouch anal anastomosis (Ta-IPAA) in patients with ulcerative colitis: a cohort study from the TaTME international database
Year: 2018
Source: ECCO '18 Vienna
Authors:

G. Pellino1,2*, K. Sahnan2,3, M. Penna3,4, S. Adegbola2,3, P. Chandrasinghe2,3,5, A. Spinelli6,7, R. Hompes4, J. Warusavitarne2,3, on behalf of the International TaTME Registry Collaborative.

Created: Thursday, 21 February 2019, 9:14 AM
OP018: High-fat diet and inflammation drive intestinal fibrosis enhancing epithelial–mesenchymal transition through the activation of S1P3 signalling
Year: 2018
Source: ECCO '18 Vienna
Authors:

C. Mascaraque1, S. Elangovan2, L. Petti1, A. Piontini2, C. Correale1, V. Arena3, B. Romano1, F. Ungaro2, V. Garlatti2, S. D’Alessio2, G. Fiorino1, A. Spinelli2,4, S. Danese1,2, S. Vetrano2*

Created: Thursday, 21 February 2019, 9:14 AM
OP018: Optimal anti-TNF stop week during pregnancy depends on anti-TNF type
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Kanis S., de Lima A., van der Woude C.

Created: Wednesday, 20 February 2019, 10:36 AM
OP018: The impact of Crohns Disease-TReatment-with-EATing diet (CD-TREAT diet) and exclusive enteral nutrition on healthy gut bacteria metabolism
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

V. Svolos*1, R. Hansen2, K. Hughes1, U. Z. Ijaz3, C. Quince4, D. Gaya5, R. Russell2, K. Gerasimidis1

Created: Friday, 22 February 2019, 9:49 AM
OP019: Correlation of clinical and endoscopic outcomes in patients with active Crohn's disease treated with mongersen (GED-0301)
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Feagan B.*1, Colombel J.-F.2, Rossiter G.3, Li X.3, Usiskin K.3, Zhan X.3, Sands B.2

Created: Wednesday, 20 February 2019, 10:36 AM
OP019: Efficacy and safety of oral tofacitinib as induction therapy in patients with moderate-to-severe ulcerative colitis: results from 2 phase 3 randomised controlled trials
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

W. J. Sandborn1, B. E. Sands2, G. D’Haens*3, S. Vermeire4, S. Schreiber5, S. Danese6, J. Panés7, B. G. Feagan8, W. Reinisch9, W. Niezychowski10, G. Friedman10, N. Lawendy10, D. Yu10, D. Woodworth10, A. Mukherjee11, P. Healey11, H. Zhang10, C. Su10

Created: Friday, 22 February 2019, 9:49 AM
OP019: In faecal microbiota transplantation (FMT) for ulcerative colitis, fusobacterium is associated with lack of remission, while metabolic shifts to starch degradation and short-chain fatty acid production are associated with remission (FOCUS study)
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Paramsothy1,2*, M. Kamm3,4, S. Nielsen1, N. Deshpande1, J. Faith2, J. Clemente2, R. Paramsothy5, A. Walsh6, J. van den Bogaerde7, D. Samuel8, R. Leong8, S. Connor5, W. Ng5, E. Lin9, M. Wilkins1, J.-F. Colombel2, T. Borody9, H. Mitchell1, N. Kaakoush1

Created: Thursday, 21 February 2019, 9:14 AM
OP01: Comparison of fecal transplantation, fecal transplantation with the novel UC diet or the UC diet alone for Refractory Mild to Moderate Active Ulcerative Colitis: The CRAFT UC randomized controlled trial
Year: 2021
Source: ECCO'21 Virtual
Authors: Levine, A.(1,2);Scaldaferri, F.(3,4);Sarbagili Shabat, C.(1,2);Zittan, E.(5);Hirsch, A.(2,6);Mentella, M.C.(7);Musca , T.(7);Cohen, N.A.(6);Ron, Y.(6);Fliss Isakov , N.(6);Pfeffer, J.(6);Yaakov, M.(1);Fanali, C.(4);Turchini , L.(4);Masucci, L.(8,9);Quaranta, G.(8,9);Anastasia, G.(10);Weinberger, A.(10);Kopylov , U.(2,11);Maharshak, N.(2,6)
Created: Wednesday, 2 June 2021, 4:12 PM
OP01: In-depth characterisation of host genetics and gut microbiome unravels novel host–microbiome interactions in inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Hu*1, A. Vich Vila1, R. Gacesa1, V. Collij1, R. Xavier2, C. Stevens3, M. Daly3, C. Wijmenga4, H. van Dullemen1, G. Dijkstra1, M. Visschedijk1, E. Festen1, J. Fu5, A. Kurilshikov4, A. Zhernakova4, R. Weersma1

Created: Friday, 22 February 2019, 9:41 AM
OP01: Sequencing-based gene network analysis reveals a profound role for ferroptosis key gene GPX4 in post-operative endoscopic recurrence in Crohn's disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Verstockt, S.(1)*;Machiels, K.(1);Dehairs, J.(2);Rems, K.(1);De Greef, I.(1);Jans, D.(3);Sabino, J.(1,4);Ferrante, M.(1,4);Vermeire, S.(1,4);Verstockt, B.(1,4);
Created: Friday, 14 July 2023, 10:43 AM
OP01: Withdrawal of infliximab or anti-metabolite therapy in Crohn’s Disease patients in sustained remission on combination therapy: A randomized unblinded controlled trial (SPARE)
Year: 2022
Source: ECCO'22
Authors: LouisJ, E.(1);Resche-Rigon, M.(2);Laharie, D.(3);Satsangi, J.(4);Ding, N.(5);Preiss, J.(6);d'haens, G.(7);picon, L.(8);bossuyt, P.(9);vuitton, L.(10);irving, P.(11);bouhnik, Y.(12);viennot, S.(13);lamb, C.(14);pollock, R.(15);baert, F.(16);nachury, M.(17);mathurin, F.(18);Gilletta, C.(19);colombel, J.F.(20);hertervig, E.(21);
Created: Friday, 11 February 2022, 3:52 PM
OP02 Impact of therapeutic strategies on intestinal resection rate in paediatric inflammatory bowel diseases: A population-based cohort study over a 24-year period (1988–2011)
Year: 2020
Source:

ECCO'20 Vienna

Authors:

D. Ley1, A. Leroyer2, C. Dupont3, H. Sarter2, V. Bertrand4, C. Spyckerelle5, N. Guillon2, B. Pariente6, G. Savoye7, D. Turck1, C. Gower-Rousseau2, M. Fumery8, Epimad group

Created: Thursday, 30 January 2020, 10:12 AM
OP020: Filgotinib, a selective JAK1 inhibitor, induces clinical remission in patients with moderate-to-severe Crohns disease: interim analysis from the Phase 2 FITZROY study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. Vermeire*1, S. Schreiber2, R. Petryka3, T. Kuehbacher4, X. Hebuterne5, X. Roblin6, M. Klopocka7, E. Goldis8, M. Wisniewska-Jarosinska9, A. Baranovsky10, R. Sike11, C. Tasset12, A. Van der Aa12, P. Harrison12

Created: Friday, 22 February 2019, 9:49 AM
OP020: Recent anti-TNF exposure predicts lower vedolizumab trough concentrations in patients with Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Gils A.*1, Dreesen E.1, Compernolle G.1, Peeters M.1, Brouwers E.1, Tops S.1, Ballet V.2, Noman M.2, Ferrante M.2, Van Assche G.2, Vermeire S.2

Created: Wednesday, 20 February 2019, 10:36 AM
OP020: The clinical determinants affect gut microbial profile of inflammatory bowel disease patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

P. Juillerat1*, B. Yilmaz2, R. Wiest1,2, G. Rogler3, A.J. Macpherson1

Created: Thursday, 21 February 2019, 9:14 AM
OP021: Autologous haematopoietic stem cell transplantation for Crohn’s disease: a retrospective study from the European Society for Blood & Marrow Transplantation (EBMT) Autoimmune Diseases Working Party
Year: 2018
Source: ECCO '18 Vienna
Authors:

C. Brierley1*, C. Castilla-Llorente2, M. Labopin3, M. Badoglio3, M. Rovira4, E. Ricart5, D. Dierickx6, S. Vermeire7, P. Hasselblatt8, J. Finke9, F. Onida10, A. Cassinotti11, J. Satsangi12, M. Kazmi13, A. López-Sanromán14, D. Farge15, S. Travis16, C. Hawkey17, J. Snowden18

Created: Thursday, 21 February 2019, 9:14 AM
OP021: Efficacy and safety of oral tofacitinib for maintenance therapy in patients with moderate-to-severe Crohns disease: results of a Phase 2b randomised placebo-controlled trial
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

G. D’Haens*1, R. Pannaccione2, P. D. R. Higgins3, J.-F. Colombel3, B. G. Feagan4, M. Moscariello5, G. Chan5, P. Healey6, W. Niezychowski5, W. Wang5, A. Marren5, E. Maller5

Created: Friday, 22 February 2019, 9:49 AM